Coeptis Therapeutics Files Q1 2025 10-Q
Ticker: COEPW · Form: 10-Q · Filed: May 14, 2025 · CIK: 1759186
Sentiment: neutral
Topics: 10-Q, biotech, financials
TL;DR
Coeptis Therapeutics filed its Q1 2025 10-Q. Financials updated.
AI Summary
Coeptis Therapeutics Holdings, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly Bull Horn Holdings Corp., is involved in biological products. Key financial data and operational details for the first quarter of 2025 are presented in this filing.
Why It Matters
This filing provides investors with an update on Coeptis Therapeutics' financial health and operational status for the first quarter of 2025, crucial for understanding its current trajectory.
Risk Assessment
Risk Level: medium — As a biotechnology company, Coeptis Therapeutics is subject to inherent risks associated with drug development, regulatory approvals, and market acceptance.
Key Players & Entities
- Coeptis Therapeutics Holdings, Inc. (company) — Filer of the 10-Q
- Bull Horn Holdings Corp. (company) — Former name of Coeptis Therapeutics Holdings, Inc.
- 20250331 (date) — End of the reporting period
- 20250514 (date) — Filing date of the 10-Q
FAQ
What was the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing was March 31, 2025.
What is the company's former name?
The company's former name was Bull Horn Holdings Corp., with a date of name change on November 15, 2018.
What is the company's primary industry classification?
The company's Standard Industrial Classification is Biological Products (No Diagnostic Substances) [2836].
Where is Coeptis Therapeutics Holdings, Inc. located?
The company's business and mailing address is 105 Bradford Road, Suite 420, Wexford, PA 15090.
When was this 10-Q form filed?
This 10-Q form was filed on May 14, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Coeptis Therapeutics Holdings, Inc. (COEPW).